The Breast Journal · 2006 · 90 citations · 13 references
MedicineBiostatisticsPreventive MedicineCancer EpidemiologyCancer ScreeningEpidemiologic MethodsCancer DiagnosisCancer Early DetectionCancer SurveillancePopulation ScreeningScreeningCancer Screening EpidemiologyMammographic Screening EpidemiologyMammographyMean Sojourn TimeMultistate Survival ModelsOverdiagnosis In Cancer ScreeningScreening MammographyScreens
The goal of this research was to estimate the overdiagnosis at the first and second screens of the mammography screening program in Copenhagen, Denmark. This study involves a mammography service screening program in Copenhagen, Denmark, with 35,123 women screened at least once. We fit multistate models to the screening data, including preclinical incidence of progressive cancers and nonprogressive (i.e., overdiagnosed) cancers. We estimated mean sojourn time as 2.7 years (95% confidence interval [CI] 2.2-3.1) and screening test sensitivity as 100% (95% CI 99.8-100). Overdiagnosis was estimated to be 7.8% (95% CI 0.3-26.5) at the first screen and 0.5% (95% CI 0.02-2.1) at the second screen. This corresponds to 4.8% of all cancers diagnosed among participants during the first two invitation rounds and following intervals. A modest overdiagnosis was estimated for the Copenhagen screening program, deriving almost exclusively from the first screen. The CIs were very broad, however, and estimates from larger datasets are warranted.
13
Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study
Anne Helene Olsen, Sisse Helle Njor, Ilse Vejborg et al. · BMJ · 2005 · 200 citations · Full text